Medy-Tox Inc.
Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Medy-Tox Inc. is a global biopharmaceutical company focused on the research, development, and commercialization of aesthetic and therapeutic products. The company's core portfolio consists of botulinum toxin preparations, including its flagship brands Neuronox®, INNOTOX®, and Coretox®, and a range of hyaluronic acid dermal fillers, such as Neuramis®. A pioneer in the South Korean market, Medy-Tox has established a significant presence in the global botulinum toxin industry, distinguished by its robust R&D pipeline and the development of multiple unique formulations. The company also produces a dermocosmetic line under the NEURADERM brand and operates an extensive global network to market its products worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-10 00:00 |
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
|
Korean | 5.3 KB | ||
| 2025-08-26 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.5 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.7 MB | ||
| 2025-08-11 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.4 KB | ||
| 2025-07-22 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 18.2 KB | ||
| 2025-07-16 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 57.4 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.4 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.0 MB | ||
| 2025-05-12 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.5 KB | ||
| 2025-04-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.3 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.0 KB | ||
| 2025-03-25 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 28.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.6 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 604.4 KB | ||
| 2025-03-13 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
